190 related articles for article (PubMed ID: 9810272)
1. Betulinic acid inhibits aminopeptidase N activity.
Melzig MF; Bormann H
Planta Med; 1998 Oct; 64(7):655-7. PubMed ID: 9810272
[TBL] [Abstract][Full Text] [Related]
2. Betulinic acid inhibits growth factor-induced in vitro angiogenesis via the modulation of mitochondrial function in endothelial cells.
Kwon HJ; Shim JS; Kim JH; Cho HY; Yum YN; Kim SH; Yu J
Jpn J Cancer Res; 2002 Apr; 93(4):417-25. PubMed ID: 11985792
[TBL] [Abstract][Full Text] [Related]
3. Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection.
Cichewicz RH; Kouzi SA
Med Res Rev; 2004 Jan; 24(1):90-114. PubMed ID: 14595673
[TBL] [Abstract][Full Text] [Related]
4. [Advances in the study of structural modifications and biological activities of betulinic acids].
Lan P; Zhang DM; Chen WM; Ye WC
Yao Xue Xue Bao; 2010 Nov; 45(11):1339-45. PubMed ID: 21361032
[TBL] [Abstract][Full Text] [Related]
5. Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects.
Bauvois B; Dauzonne D
Med Res Rev; 2006 Jan; 26(1):88-130. PubMed ID: 16216010
[TBL] [Abstract][Full Text] [Related]
6. Betulinic acid and its derivatives: a review on their biological properties.
Yogeeswari P; Sriram D
Curr Med Chem; 2005; 12(6):657-66. PubMed ID: 15790304
[TBL] [Abstract][Full Text] [Related]
7. A small-molecule antagonist of virion assembly.
Neamati N
Expert Opin Investig Drugs; 2001 Sep; 10(9):1767-70. PubMed ID: 11785455
[No Abstract] [Full Text] [Related]
8. New 3-O-acyl betulinic acids from Strychnos vanprukii Craib.
Nguyen QC; Nguyen VH; Santarsiero BD; Mesecar AD; Nguyen MC; Soejarto DD; Pezzuto JM; Fong HH; Tan GT
J Nat Prod; 2004 Jun; 67(6):994-8. PubMed ID: 15217281
[TBL] [Abstract][Full Text] [Related]
9. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis.
Pisha E; Chai H; Lee IS; Chagwedera TE; Farnsworth NR; Cordell GA; Beecher CW; Fong HH; Kinghorn AD; Brown DM
Nat Med; 1995 Oct; 1(10):1046-51. PubMed ID: 7489361
[TBL] [Abstract][Full Text] [Related]
10. Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors.
Chintharlapalli S; Papineni S; Ramaiah SK; Safe S
Cancer Res; 2007 Mar; 67(6):2816-23. PubMed ID: 17363604
[TBL] [Abstract][Full Text] [Related]
11. Transient activation of EGFR/AKT cell survival pathway and expression of survivin contribute to reduced sensitivity of human melanoma cells to betulinic acid.
Qiu L; Wang Q; Di W; Jiang Q; Schefeller E; Derby S; Wanebo H; Yan B; Wan Y
Int J Oncol; 2005 Sep; 27(3):823-30. PubMed ID: 16077934
[TBL] [Abstract][Full Text] [Related]
12. Effect of betulinic acid on intracellular-free Ca(2+) levels in Madin Darby canine kidney cells.
Chou KJ; Fang HC; Chung HM; Cheng JS; Lee KC; Tseng LL; Tang KY; Jan CR
Eur J Pharmacol; 2000 Nov; 408(2):99-106. PubMed ID: 11080515
[TBL] [Abstract][Full Text] [Related]
13. Betulinic acid, a catalytic inhibitor of topoisomerase I, inhibits reactive oxygen species-mediated apoptotic topoisomerase I-DNA cleavable complex formation in prostate cancer cells but does not affect the process of cell death.
Ganguly A; Das B; Roy A; Sen N; Dasgupta SB; Mukhopadhayay S; Majumder HK
Cancer Res; 2007 Dec; 67(24):11848-58. PubMed ID: 18089815
[TBL] [Abstract][Full Text] [Related]
14. Effects of betulinic acid alone and in combination with irradiation in human melanoma cells.
Selzer E; Pimentel E; Wacheck V; Schlegel W; Pehamberger H; Jansen B; Kodym R
J Invest Dermatol; 2000 May; 114(5):935-40. PubMed ID: 10771474
[TBL] [Abstract][Full Text] [Related]
15. Betulinic acid, a potent inhibitor of eukaryotic topoisomerase I: identification of the inhibitory step, the major functional group responsible and development of more potent derivatives.
Chowdhury AR; Mandal S; Mittra B; Sharma S; Mukhopadhyay S; Majumder HK
Med Sci Monit; 2002 Jul; 8(7):BR254-65. PubMed ID: 12118187
[TBL] [Abstract][Full Text] [Related]
16. Structure and Anti-HIV Activity of Betulinic Acid Analogues.
Huang QX; Chen HF; Luo XR; Zhang YX; Yao X; Zheng X
Curr Med Sci; 2018 Jun; 38(3):387-397. PubMed ID: 30074203
[TBL] [Abstract][Full Text] [Related]
17. Self-assembled betulinic acid augments immunomodulatory activity associates with IgG response.
Dash SK; Chattopadhyay S; Tripathy S; Dash SS; Das B; Mandal D; Mahapatra SK; Bag BG; Roy S
Biomed Pharmacother; 2015 Oct; 75():205-17. PubMed ID: 26256937
[TBL] [Abstract][Full Text] [Related]
18. Betulinic acid derivatives as human immunodeficiency virus type 2 (HIV-2) inhibitors.
Dang Z; Lai W; Qian K; Ho P; Lee KH; Chen CH; Huang L
J Med Chem; 2009 Dec; 52(23):7887-91. PubMed ID: 19526990
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anti-HIV activity of 3-alkylamido-3-deoxy-betulinic acid derivatives.
Kashiwada Y; Chiyo J; Ikeshiro Y; Nagao T; Okabe H; Cosentino LM; Fowke K; Morris-Natschke SL; Lee KH
Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1387-90. PubMed ID: 10993248
[TBL] [Abstract][Full Text] [Related]
20. Anti-AIDS agents 81. Design, synthesis, and structure-activity relationship study of betulinic acid and moronic acid derivatives as potent HIV maturation inhibitors.
Qian K; Kuo RY; Chen CH; Huang L; Morris-Natschke SL; Lee KH
J Med Chem; 2010 Apr; 53(8):3133-41. PubMed ID: 20329730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
